Issue #1December 30, 2025
Your Weekly Gila Dose: Issue 1, Small wins, big transformations 🦎
Published December 30, 2025
Editor-in-chief: Sezen Soykut, ICF ACC · Gila
Listen to this issue
Your Weekly Gila Dose: Issue 1, Small wins, big transformations 🦎
0:00
0:00
Welcome to Gila GLP-1 & Weight Loss. This week’s curated highlights span safety and access (UK warning on social-media jabs; FDA’s oral Wegovy), emerging benefits (asthma risk in teens), and durability (body-composition and function). You’ll also find a physician’s personal story, community wins, and practical videos on visceral fat, protein-first snacks, and alcohol strategies. Reminder: this newsletter shares curated information—not medical advice. For personal guidance, partner with your clinician.
“"You do not rise to the level of your goals. You fall to the level of your systems." — James Clear”
Science & News
News
🫁 Teen Asthma Win: In a large U.S. cohort, adolescents with obesity and asthma on GLP-1s had about half the risk of exacerbations, with fewer ER visits and steroid bursts. For us, this hints at a dual benefit—weight management plus possible anti-inflammatory effects—though randomized trials are still needed. If you or your teen juggles asthma and weight, talk to your clinician about whether a GLP-1 fits your plan while you keep nailing the basics (controller meds, protein, daily movement).
News
⚠️ UK Alert: Skip social-media weight-loss jabs. Why it matters: counterfeit or mishandled pens can be under/overdosed, contaminated, or contain unlicensed drugs (like fake retatrutide), putting your health and progress at risk. Action for us: only use licensed GLP-1s with a valid prescription from a registered pharmacy, avoid miracle claims and ultra-low prices, and if access is tough, talk to your clinician about safe pathways and waitlists—never buy from DMs, salons, or Telegram.
News
💊 Big Shift: FDA clears once-daily Wegovy pill. Why it matters: same weight-loss power as the shot (avg ~16.6% in trials; about 1 in 3 lost ≥20%) with the convenience of a pill—making adherence, travel, and needle-avoidance easier for us. Timing note: US launch is expected early 2026, so if this fits your plan, start talking with your clinician about insurance, supply, and switching strategy.
News
💪 Study Watch: 8-Year Look AHEAD—Fat Down, Muscle Up = Better Function. Translation for us: in older adults with T2D, fat regain predicted slower walking and worse performance, while lean loss predicted weaker strength—even though the lifestyle group still moved better overall. For you on GLP-1s or lifestyle alone: anchor protein (about 1.0–1.2 g/kg/day), lift 2–3x/week, and keep steps up to defend muscle and mobility as you lose.
News
🧠 Food noise is biology, not a character flaw. This MedPage Today feature follows a physician whose semaglutide turned down relentless hunger and gave her back focus, confidence, and capacity—proof that GLP-1s can be life-changing when combined with care. For us: balance side-effect chatter with benefits, use the quiet hunger window to build protein-forward meals, steps, and sleep, and give yourself permission to seek help sooner, not later.
Community Insights
Reddit
🎉 Huge Win, Big Lessons: On Reddit, a member dropped 56 lbs in 8 months—size 14 to 2—by stacking semaglutide with intermittent fasting, cutting alcohol, gluten, and dairy, and training 4 days/week, even after Graves-related thyroid swings and insulin resistance. For your journey, it proves meds plus consistent habits win: we use the GLP-1 to quiet appetite, you lock in protein-forward meals, regular movement, and alcohol-light weeks, and momentum does the rest.
Reddit
🎉 Reddit Win: 50 lbs Down Since January On Reddit, a member shared a 50‑lb loss since January and says they’ve never felt better. This reminds us that steady consistency beats perfection—if you’re on GLP‑1s, lock in the basics (protein-forward meals, daily movement, hydration, and sleep) so the medication can do its best work for you.
Reddit
🐾 Non-Scale Victory: Energy That Changes Lives On Reddit, a member shared that their Aussie mix finally gets full-on playtime because their energy is up and joints feel better—sometimes the dog taps out first. For your journey, chase wins like this: plan joyful, low-impact movement, prioritize protein to protect muscle and joints, and track energy and mobility as seriously as the scale.
Reddit
🛡️ Body Positivity Cuts Both Ways On Reddit, a member with PCOS and type 2 diabetes described real health gains on a GLP‑1, yet faced shaming for “not deserving” medication. The lesson for us: weight tools are healthcare, not vanity—anchor your plan in your diagnosis, outcomes, and your doctor’s guidance. For your journey, keep a simple talk-track (“I’m following my doctor’s plan for PCOS/T2D”), log wins (A1c, energy, cycles), and let results—not opinions—be your compass.
Must Watch
YouTube
🍿 Watch This: Visceral Fat, Muscle, and GLP-1s After 50 This video breaks down why visceral belly fat—not just the scale—drives artery risk after 50, how muscle acts like heart armor, and where GLP-1s (Ozempic) can help. If you’re on or considering a GLP-1, use this game plan: prioritize protein + resistance training, track waist and strength (not just pounds), and target belly fat while preserving muscle—so we protect our hearts for the long haul.
YouTube
🍿 Watch This: Mounjaro Pens, Muscle Loss Myth, and a 30-Day Metabolic Experiment This creator brings new, carefully recorded click-count data on Mounjaro pens that can change how we dose and set expectations—super useful for all of us tweaking our plans. He tackles the muscle-loss panic with context and kicks off a CGM + ketone-monitor trial to test metabolic flexibility in real life, giving you smarter tactics to protect muscle while losing fat.
YouTube
🍿 Watch This: Target GLP-1 Snack Haul—High Protein, Real Food Wins. You’ll get a quick label-reading walkthrough plus grab-and-go, protein-forward picks that won’t overwhelm GLP-1 appetite—perfect when time is tight. We love the clear whole-food vs “nutrition-ish” breakdown; use it before your next Target run to boost satiety and keep your plan simple.
YouTube
🍿 Watch This: Wegovy Pill Is Here Bloomberg’s interview with Novo Nordisk’s president signals a bigger, more accessible GLP‑1 market—oral Wegovy could mean easier adherence for needle‑averse folks and better travel flexibility for all of us. If you're on or considering GLP‑1s, ask your prescriber about pill vs. injection trade‑offs (dosing rules, side effects, availability) and call your insurer now—coverage and copays may shift fast as competition with Zepbound heats up.
YouTube
🍿 Watch This Before Holiday Drinks on GLP‑1s Dr. Dan explains why alcohol hits harder on Ozempic/Wegovy/Mounjaro/Zepbound and gives us a 5‑rule playbook to stay social without derailing progress (pace it, protein first, plan ahead—and beat the 2 A.M. pizza problem). You’ll also get the red‑flag exceptions (pancreatitis, active liver disease, diabetes‑related hypo risk) plus a surprising bonus: many of us lose the taste for alcohol—use that to your advantage.
Keep using the quieter appetite window to build sustainable habits—protein, movement, sleep, kindness to yourself. We’re cheering you on. For dosing, side effects, or switching questions, contact your healthcare team.
Ready to start your GLP-1 journey?
Gila helps you build lasting habits, understand your body, and stay on track. Join the pilot for free.
Join the Pilot